Stock Price

48,00 SEK

2.57% ROA

5.1% ROE

15.62x PER

Market Cap.

2.550.724.800,00 SEK

175.02% DER

0% Yield

1.53% NPM

Humana AB (publ) Stock Analysis

Humana AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Humana AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Humana AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Humana AB (publ) Technical Stock Analysis
# Analysis Recommendation

Humana AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Humana AB (publ) Revenue
Year Revenue Growth
2012 2.981.660.000
2013 3.489.000.000 14.54%
2014 5.065.000.000 31.12%
2015 5.593.000.000 9.44%
2016 6.362.000.000 12.09%
2017 6.542.000.000 2.75%
2018 6.714.000.000 2.56%
2019 7.446.000.000 9.83%
2020 7.771.000.000 4.18%
2021 8.186.000.000 5.07%
2022 9.203.000.000 11.05%
2023 9.592.000.000 4.06%
2023 9.649.000.000 0.59%
2024 9.628.000.000 -0.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Humana AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Humana AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 39.000.000 100%
2014 106.000.000 63.21%
2015 133.000.000 20.3%
2016 193.000.000 31.09%
2017 187.000.000 -3.21%
2018 0 0%
2019 64.000.000 100%
2020 893.000.000 92.83%
2021 907.000.000 1.54%
2022 1.059.000.000 14.35%
2023 0 0%
2023 1.178.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Humana AB (publ) EBITDA
Year EBITDA Growth
2012 211.646.000
2013 232.000.000 8.77%
2014 356.000.000 34.83%
2015 363.000.000 1.93%
2016 393.000.000 7.63%
2017 380.000.000 -3.42%
2018 467.000.000 18.63%
2019 430.000.000 -8.6%
2020 510.000.000 15.69%
2021 570.000.000 10.53%
2022 478.000.000 -19.25%
2023 688.000.000 30.52%
2023 457.000.000 -50.55%
2024 424.000.000 -7.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Humana AB (publ) Gross Profit
Year Gross Profit Growth
2012 376.139.000
2013 294.000.000 -27.94%
2014 491.000.000 40.12%
2015 526.000.000 6.65%
2016 653.000.000 19.45%
2017 593.000.000 -10.12%
2018 493.000.000 -20.28%
2019 793.000.000 37.83%
2020 1.732.000.000 54.21%
2021 1.853.000.000 6.53%
2022 1.950.000.000 4.97%
2023 2.284.000.000 14.62%
2023 2.119.000.000 -7.79%
2024 2.080.000.000 -1.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Humana AB (publ) Net Profit
Year Net Profit Growth
2012 43.978.000
2013 111.000.000 60.38%
2014 38.000.000 -192.11%
2015 28.000.000 -35.71%
2016 148.000.000 81.08%
2017 194.000.000 23.71%
2018 246.000.000 21.14%
2019 188.000.000 -30.85%
2020 262.000.000 28.24%
2021 276.000.000 5.07%
2022 210.000.000 -31.43%
2023 328.000.000 35.98%
2023 176.000.000 -86.36%
2024 84.000.000 -109.52%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Humana AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 2 100%
2014 1 0%
2015 1 0%
2016 3 100%
2017 4 33.33%
2018 5 25%
2019 4 -33.33%
2020 5 25%
2021 6 20%
2022 4 -25%
2023 7 33.33%
2023 4 -100%
2024 2 -200%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Humana AB (publ) Free Cashflow
Year Free Cashflow Growth
2012 155.178.000
2013 172.000.000 9.78%
2014 110.000.000 -56.36%
2015 228.000.000 51.75%
2016 -304.000.000 175%
2017 90.000.000 437.78%
2018 158.000.000 43.04%
2019 403.000.000 60.79%
2020 528.000.000 23.67%
2021 572.000.000 7.69%
2022 441.000.000 -29.71%
2023 -34.000.000 1397.06%
2023 451.000.000 107.54%
2024 84.000.000 -436.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Humana AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2012 178.597.000
2013 196.000.000 8.88%
2014 156.000.000 -25.64%
2015 274.000.000 43.07%
2016 -161.000.000 270.19%
2017 241.000.000 166.8%
2018 332.000.000 27.41%
2019 631.000.000 47.39%
2020 661.000.000 4.54%
2021 689.000.000 4.06%
2022 633.000.000 -8.85%
2023 -34.000.000 1961.76%
2023 621.000.000 105.48%
2024 84.000.000 -639.29%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Humana AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2012 23.419.000
2013 24.000.000 2.42%
2014 46.000.000 47.83%
2015 46.000.000 0%
2016 143.000.000 67.83%
2017 151.000.000 5.3%
2018 174.000.000 13.22%
2019 228.000.000 23.68%
2020 133.000.000 -71.43%
2021 117.000.000 -13.68%
2022 192.000.000 39.06%
2023 0 0%
2023 170.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Humana AB (publ) Equity
Year Equity Growth
2012 628.484.000
2013 853.000.000 26.32%
2014 986.000.000 13.49%
2015 1.093.000.000 9.79%
2016 1.726.000.000 36.67%
2017 1.891.000.000 8.73%
2018 2.147.000.000 11.92%
2019 2.306.000.000 6.9%
2020 2.354.000.000 2.04%
2021 2.553.000.000 7.79%
2022 2.739.000.000 6.79%
2023 2.910.000.000 5.88%
2023 2.925.000.000 0.51%
2024 2.984.000.000 1.98%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Humana AB (publ) Assets
Year Assets Growth
2012 1.737.369.000
2013 2.196.000.000 20.88%
2014 3.660.000.000 40%
2015 3.838.000.000 4.64%
2016 4.960.000.000 22.62%
2017 5.060.000.000 1.98%
2018 5.218.000.000 3.03%
2019 8.231.000.000 36.61%
2020 8.044.000.000 -2.32%
2021 9.002.000.000 10.64%
2022 9.806.000.000 8.2%
2023 9.760.000.000 -0.47%
2023 10.029.000.000 2.68%
2024 10.205.000.000 1.72%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Humana AB (publ) Liabilities
Year Liabilities Growth
2012 1.108.885.000
2013 1.343.000.000 17.43%
2014 2.674.000.000 49.78%
2015 2.745.000.000 2.59%
2016 3.234.000.000 15.12%
2017 3.169.000.000 -2.05%
2018 3.071.000.000 -3.19%
2019 5.925.000.000 48.17%
2020 5.690.000.000 -4.13%
2021 6.449.000.000 11.77%
2022 7.067.000.000 8.74%
2023 6.850.000.000 -3.17%
2023 7.104.000.000 3.58%
2024 7.221.000.000 1.62%

Humana AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
201.19
Net Income per Share
3.07
Price to Earning Ratio
15.62x
Price To Sales Ratio
0.27x
POCF Ratio
3.51
PFCF Ratio
5.27
Price to Book Ratio
0.79
EV to Sales
0.73
EV Over EBITDA
15.33
EV to Operating CashFlow
10.76
EV to FreeCashFlow
14.54
Earnings Yield
0.06
FreeCashFlow Yield
0.19
Market Cap
2,55 Bil.
Enterprise Value
7,04 Bil.
Graham Number
64.96
Graham NetNet
-120.07

Income Statement Metrics

Net Income per Share
3.07
Income Quality
4.45
ROE
0.05
Return On Assets
0.01
Return On Capital Employed
0.05
Net Income per EBT
0.77
EBT Per Ebit
0.5
Ebit per Revenue
0.04
Effective Tax Rate
0.29

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.22
Operating Profit Margin
0.04
Pretax Profit Margin
0.02
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
13.67
Free CashFlow per Share
10.12
Capex to Operating CashFlow
-0.26
Capex to Revenue
-0.02
Capex to Depreciation
-0.31
Return on Invested Capital
0.03
Return on Tangible Assets
0.03
Days Sales Outstanding
43.32
Days Payables Outstanding
11.38
Days of Inventory on Hand
0
Receivables Turnover
8.43
Payables Turnover
32.08
Inventory Turnover
0
Capex per Share
-3.55

Balance Sheet

Cash per Share
13,01
Book Value per Share
61,01
Tangible Book Value per Share
-31.26
Shareholders Equity per Share
61.01
Interest Debt per Share
106.78
Debt to Equity
1.75
Debt to Assets
0.5
Net Debt to EBITDA
9.77
Current Ratio
0.93
Tangible Asset Value
-1,50 Bil.
Net Current Asset Value
-5,22 Bil.
Invested Capital
1.75
Working Capital
-0,16 Bil.
Intangibles to Total Assets
0.44
Average Receivables
1,11 Bil.
Average Payables
0,25 Bil.
Average Inventory
0
Debt to Market Cap
2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Humana AB (publ) Dividends
Year Dividends Growth
2017 1
2019 1 0%

Humana AB (publ) Profile

About Humana AB (publ)

Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. It operates through five segments: Individual & Family, Personal Assistance, Elderly Care, Finland, and Norway segments. The Individual & Family segment provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; interim and regular family-based care services; special service housing; outpatient care services; assisted living homes; and specially adapted housing for individuals with functional impairments and special education schools. The Personal Assistance segment offers care services and assistance to individuals with functional impairments. The Elderly Care segment provides elderly care home services. The Finland segment offers individual and family care for children, young people and families with psychiatric diagnoses or psychosocial disorders; special service housing for individuals with functional impairments; elderly care homes; and elderly day care services. The Norway segment provides individual and family care, personal assistance, and special service housing for individuals with functional impairments. The company was founded in 2001 and is headquartered in Stockholm, Sweden.

CEO
Ms. Johanna Rastad
Employee
11.128
Address
Warfvinges väg 39
Stockholm, 112 51

Humana AB (publ) Executives & BODs

Humana AB (publ) Executives & BODs
# Name Age
1 Maria Jansson
Head of Sustainability & Sustainability Manager
70
2 Mr. Adam Nerell
Chief Information Officer
70
3 Ms. Nina Marklund Krantz
Director of Human Resources
70
4 Ms. Johanna Rastad
President & Chief Executive Officer
70
5 Mr. Fredrik Larsson
Chief Financial Officer
70
6 Mr. Hans Dahlgren
Chief Executive Officer of Humana Assistans & Director of Communications
70
7 Ewelina Pettersson
Head of Investor Relations
70

Humana AB (publ) Competitors